The optimization of recombinant antibody production in Chinese Hamster Ovary (CHOK1) cells is a crucial aspect of biopharmaceutical development. To maximize production, various approaches are employed, including molecular engineering of the host cells and optimization of growth conditions. Moreover, utilization of advanced production systems can